Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Advancing Treat-to-Target Care in Generalized Myasthenia Gravis: Earlier Diagnosis, Standardized Assessment, and Precision Use of FcRn-Directed Therapy
Multiple dates & locations available
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
Exploring Genetic Links Between EBV Clearance and MS Risk
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Discharge Planning After Myasthenic Crisis
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
New Therapies, New Strategy: Rethinking MG Inpatient Care
Outcome Measures Capture Progression in Late-Onset TK2d
Untreated Thymidine Kinase 2 Deficiency: Mapping the Progressive Disease Course
Ryan Quigley
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.